Who to call at Cardinal Health, Inc., and when
Fundz watches for the moments Cardinal Health, Inc. starts buying, and tells you who to reach.
- An alert the day Cardinal Health, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cardinal Health, Inc., from your own LinkedIn network
Cardinal Health, Inc.
The company shared information publicly (Regulation FD). An 8-K is the notice a US public company must file within four business days of a major event.
cardinalhealth.comAI Executive Summary
AI-powered analysis of 8-K filing content
Cardinal Health extended its pharmaceutical distribution agreements with CVS Health through June 2032, reinforcing a critical long-term partnership and reaffirming fiscal 2027 EPS guidance of $12.40-$12.60.
Key Takeaways
Binding letter of intent extends Cardinal Health's pharmaceutical distribution agreement with CVS Health until June 2032, providing multi-year revenue visibility
Company reaffirmed fiscal 2027 non-GAAP EPS guidance range of $12.40 to $12.60 and long-term EPS growth guidance of 12% to 14%
1 more takeaway
Filing Overview
What This Means
Cardinal Health, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.